medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2013, Número 2

<< Anterior Siguiente >>

Ann Hepatol 2013; 12 (2)


Epidemiology of hepatocellular carcinoma in sub-Saharan Africa

Kew MC

Idioma: Ingles.
Referencias bibliográficas: 85
Paginas: 173-182
Archivo PDF: 133.32 Kb.


RESUMEN

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Parkin DM, Ferlay J, Hamdi-Cherif M, Thomas J, Wabinga H, Whelan SL. Cancer in Africa. Epidemiology and Prevention. IARC Scientific Publications. No. 153. Lyon, France: IARC Press; 2003.

  2. Stewart BW, Kleinhues P (eds.). World Cancer Report. Lyon, France: IARC Press; 2003.

  3. Boyle P. The globalisation of cancer. Lancet 2006; 75: 82-4.

  4. Berman C. In: Primary Carcinoma of the Liver. Great Britain: HK Lewis & Co.; 1951, p. 5.

  5. Oettlé AG. Cancer in Africa, especially in regions to the south of the Sahara. J Natl Cancer Inst 1964; 33: 383-439.

  6. Cook P, Burkitt DP. Cancer in Africa. Br Med Bull 1971; 27: 14-20.

  7. Kew MC. Clinical, pathologic and etiologic heterogeneity in hepatocellular carcinoma: evidence from southern Africa. Hepatology 1981; 1: 366-9.

  8. Davies JNP, Knowelden J, Wilson BA. The incidence rates of cancer in Kyadondo County, Uganda. J Natl Cancer Inst 1965; 35: 789-821.

  9. Kew MC. Hepatocellular carcinoma in Africa. In: About Cancer in Africa. Adama LY, Khayat D (eds.). Institut National Du Cancer, Boulogne Bilancourt Cedex, France; 2007.

  10. Flegg Mitchell H. Sociological aspects of cancer rate surveys in Africa. Natl Cancer Inst Monogr 1966; 25: 151-70.

  11. Wabinga HR, Parkin DM, Wabwire-Mangen F, Namboozes. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 2000; 82; 1585-92.

  12. Friis S, Storm H. Urban-rural variation in cancer incidence in Denmark. 1943-1987. Eur J Cancer 1993; 29A: 538-44.

  13. Parkin DM, Whelan SL, Ferlay J, et al. (eds.). Cancer Incidence in Five Continents. Vol VII. IARC Scientific Publications. No. 143. Lyon, France: IARC Press; 1999.

  14. Kew MC. Hepatocellular carcinoma in Africa. In: Clavien PA (ed.). Malignant Liver Tumors: Current and Emerging Therapies. 2nd. Ed. Boston: Jones and Bartlett; 2003, p. 439-48.

  15. Ahmed F, Perz JF, Kwong S, Jamison PM, Friedman C, Bell BP. National trends and disparities in the incidence of hepatocellular carcinoma: 1998-2003. Prev Chronic Dis 2008; 5: A74.

  16. Ferlay J, Shin HR, Bray F, Bray F, Edwards B, Shin HR, Forman D. Establishment of world-wide burden of cancer in 2008: GLOBCAN 2008. Int J Cancer 2010; 127: 2893-917.

  17. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.

  18. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16.

  19. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. 2002. CA Cancer J Clin 2005; 55: 74-108.

  20. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SA. Hepatocellular carcinoma; epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008; 4: 4300-8.

  21. Bergeret C, Roulet F. Au sujet des ictées graves, de la cirrhose, et du cancer primitive dufoie chezle noir d’Afrique. Act Trop 1947; 4; 210-40.

  22. Pirie JHH. Hepatic carcinoma in natives and its frequent association with schistosomiasis. S Afr J Med 1921; 17: 87-97.

  23. Steiner PE. Comparison of liver cancer and cirrhosis in nine areas in Trans Saharan Africa. Acta Unio Internat Contra Cancrum 1961; 17: 798-825.

  24. Higginson J. Primary carcinoma of the liver in Africa. Br J Cancer 1956; 10: 609-22.

  25. Alpert ME, Hutt MA, Davidson CS. Primary hepatoma in Uganda: a prospective clinical and epidemiological study of 46 patients. Am J Med 1969; 46: 794-802.

  26. Pavlica D, Samuel I. Primary carcinoma of the liver in Ethiopia. A study of 38 cases proven at post-mortem. Br J Cancer 1970; 24: 22-9.

  27. Payet M, Sankale M, Pene P, et al. Medicine D’Afrique Noire 1967; 2: 571.

  28. Doll R, Muir C, Waterhouse JAH. Cancer Incidence in Five Continents. Vol 2. Berlin: Springer; 1978.

  29. Higginson J. The geographic pathology of primary liver cancer. Cancer Res 1963; 23: 1624-33.

  30. Prates MD, Torres FO. A cancer survey in Lourenco Marques, Portuguese East Africa. J Natl Cancer Inst 1965; 35: 729-57.

  31. Peers FG, Gilman GA, Linsell CA. Dietary aflatoxins and human liver cancer: A study in Swaziland. Int J Cancer 1976; 17: 167-76.

  32. Kew MC, Fujita Y, Takahashi H, Coppins A, Wands JR. Comparison between polyclonal and first and second generation monoclonal radioimmunoassays in the detection of hepatitis B surface antigen in patients with hepatocellular carcinoma. Hepatology 1986; 6: 636-9.

  33. Muir C, Waterhouse JAH, Mack T, Powell J, Whelan S. Cancer Incidence in five continents. Vol. 5. IARCancer Research Publications. No. 88. Lyon, France: IARC Press; 1976.

  34. Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 2000; 82; 1585-92.

  35. Ocama P, Nambooze S, Opio CK, Shiels MS, Wabinga HR, Kirk GD. Trends in the incidence of primary liver cancer in Central Uganda, 1960-1980 and 1991-2005. Br J Cancer 2009; 100: 799-802.

  36. Umoh NJ, Lesi OA, Mendy M, Bah E, Akano A, Whittle H, Hainaut P, et al. Etiological differences in demographical, clinical and pathological characteristics of hepatocarcinoma in The Gambia. Liver Int 2011; 31: 215-21.

  37. McGlashan ND, Harington JS, Chelkowska E. Changes in the geographical and temporal patterns of cancer incidence among Black gold miners in South Africa. 1964-1996. Br J Cancer 2003; 6: 1361-9.

  38. Kew MC. Chronic hepatitis B virus infection and hepatocellular carcinoma in Africa. S Afr J Sci 1992; 88: 524-8.

  39. Barin F, Perrin J, Chotard JD. Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal. Progr Med Virol 1981; 27: 148-62.

  40. Botha FJ, Ritchie MJJ, Dusheiko GM, Mouton HWK, Kew MC. Hepatitis B virus carrier state in Black children in Ovamboland: Role of perinatal and horizontal transmission. Lancet 1984; 1: 1210-2.

  41. Higginson J. The epidemiology of primary carcinoma of the liver. In: Pack GT, Islami AH (eds.). Tumors of the liver. Springer: Berkin; 1970: 38-52.

  42. Kew MC, Dos Santos HA, Sherlock S. Diagnosis of primary cancer of the liver. Br Med J 1971; 4: 408-11.

  43. Kew MC, Geddes EW. Hepatocellular carcinoma in rural southern African Blacks. Medicine (Balt) 1982; 61: 98-108.

  44. Kew MC, Kassianides C, Hodkinson J, Coppins A, Paterson AC. Hepatocellular carcinoma in urban-born Blacks: frequency and relation to hepatitis B virus infection. Br Med J (Clin Res Ed) 1986; 293: 1339-41.

  45. Prates MD, Torres FO. A cancer survey in Lourenco Marques, Portuguese East Africa. J Natl Cancer Inst 1965; 35: 729-57.

  46. Kew MC, Rossouw E, Paterson A, Dusheiko GM, Whitcutt M. Hepatitis B virus status of Black women with hepatocellular carcinoma. Gastroenterology 1983; 84: 693-6.

  47. Kew MC. The possible etiologic role of the hepatitis-B virus in hepatocellular carcinoma: Evidence from Southern Africa. In: Chisari FV, (ed.). Advances in Hepatitis Research. New York: Masson Publishing; 1984, p. 203-15.

  48. Kew MC. Clinical manifestations and paraneoplastic syndromes of hepatocellular carcinoma. In: Okuda K, Ishak KG (eds.). Neoplasms of the Liver. Tokyo, Springer-Verlag.; 1987, p. 199-211.

  49. Kew MC, Marcus R, Geddes EW. Some characteristics of Mozambican Shangaans with primary hepatocellular cancer. S Afr Med J 1977; 51: 306-9.

  50. Anthony PP. Primary carcinoma of the liver: a study of 282 cases in Ugandan Africans. J Pathol 1973; 110; 37-48.

  51. Gelfand M, Castle WM, Buchanan WM. Primary carcinoma of the liver (hepatoma) in Rhodesia; a clinical study. S Afr Med J 1972; 46: 527-32.

  52. Kiire CF. Hepatocellular carcinoma in Zimbabwe. Trop Gastroenterol 1988; 9: 127-31.

  53. Fakunle YM, Ajdukiewicz AB, Greenwood BM, Edgington GM. Primary liver carcinoma (PLCC) in the Northern Guinea Sanvanna of Nigeria. Trans R Soc Trop Med Hyg 1977; 71; 335-7.

  54. Mwangi J, Gatei DG. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya. East Afr Med J 1993; 70(Suppl. 4): 34-6.

  55. Bagshawe A, Cameron HM. The clinical problem of liver cell cancer in a high incidence region. In: Cameron HM, Linsell DA, Warwick GP (eds.). Liver Cell Cancer. Elsevier: Amsterdam; 1976; 45-9.

  56. Francis TI, Smith JA. Hepatocellular carcinoma in Nigerians: a study of 144 autopsy proven cases: 1958-1968. W Afr J Med Niger Pract 1972; 21: 37-42.

  57. Olubuyide IO. The natural history of primary liver cell carcinoma: a study of 89 untreated adult Nigerians. Cent Afr J Med 1992; 38: 25-30.

  58. Seleye-Fubara D, Jebbin NJ. Hepatocellular carcinoma in Port Harcourt, Nigeria: Clinicopathologic study of 75 cases. Ann Afr Med 2007; 6: 54-7.

  59. Echejoh GO, Tanko MN, Manasseh AN, Ogala-Echejoh S, Ugoya SO, Mandong BM. Hepatocellular carcinoma in JOS, Nigeria. Niger J Med 2008; 17: 210-3.

  60. Norredam K. Primary carcinoma of the liver in Malawi: a review of 24 cases. Trop Geogr Med 1977; 29: 141-9.

  61. Diop B, Denis F, Barin F, Perrin J, Chiron JP, Goudeau A, Coursaget P, et al. Epidemiology of primary hepatocellular carcinoma in Senegal. Progr Med Virol 1981; 27: 35-40.

  62. Kashala LO, Conne B, Kalengayi MM, Kaponci Y, Frei PC, Lambert PH. Histopathological features off hepatocellular carcinoma in Zaire. Cancer 1990; 65: 130-4.

  63. Tsega E. Unusual presentations of hepatoma in Ethiopians. East Afr Med J 1981; 58: 185-91.

  64. Thomas GE, Wicks ACB, Clain DJ, Loon LA, Seggie J, Branstom B. Hepatocellular carcinoma in the Rhodesian African. Am J Dig Dis 1977; 22: 573-81.

  65. Okokwo UC, Nwosu NM, Ikoh C, Okpala OC, Ahaneku JI. The clinical and pathologic features of hepatocellular carcinoma in Nwewi, Nigeria. Niger J Med 2011; 20: 366-71.

  66. Kirk GD, Bah E, Montesano R. Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, W Africa. Carcinogenesis 2006; 27: 2070-82.

  67. Kew MC, Geddes EW. Hepatocellular carcinoma in rural southern African Blacks. Medicine (Balt) 1982; 61: 98-108.

  68. Kew MC. Hepatitis C virus and hepatocellular carcinoma in developing and developed countries. Vir Hepatit Rev 1998; 4: 259-69.

  69. Kew MC, Rossouw E, Hodkinson J, Paterson A, Dusheiko GM, Whitcutt M. Hepatitis B virus status in southern African Blacks with hepatocellular carcinoma: comparison between rural and urban patients. Hepatology 1983; 3: 65-8.

  70. Parkin DM. Cancer occurrence in developing countries. IARC Publications. No. 75. Lyon, France: IARC Press; 198-6.

  71. Sung JL, Wang TH, Yu JY. Clinical study on primary carcinoma of the liver in Taiwan. Am J Dig Dis 1967; 12: 1036-49.

  72. Kew MC, Song E, Dusheiko GM. Hepatocellular carcinoma in White South Africans: Aetiological considerations. S Afr Med J 1984; 66: 835-7.

  73. Francis TI, Smith JA. Hepatocellular carcinoma in Nigerians: a study of 144 autopsy proven cases: 1958-1968. W Afr J Med Niger Pract 1972; 21: 37-42.

  74. Anthony PP. Primary carcinoma of the liver: a study of 282 cases in Ugandan Africans. J Pathol 1973; 110; 37-48.

  75. Kew MC, Macerollo P. The effect of age on the etiological role of the hepatitis B virus in hepatocellular carcinoma in Blacks. Gastroenterology 1988; 94; 439-42.

  76. San Jose D, Cady A, West M, Comet B, Zimmerman HJ. Primary carcinoma of the liver. Am J Dig Dis 1965; 10: 657-74.

  77. Linsell CA. Liver Cancer and Mycotoxins. In: Williams AO, O’Connor GT, De-The GB, Johnson CA (eds). Virus-associated Cancers in Africa. IARC Publications. No. 63. Lyon, France: IARC Press; 1984: 161-5.

  78. Kew MC. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver Int 2003a; 23: 405-9.

  79. Hammond MG, Appadodoo B, Brain P. HLA and cancer in South African Negroes. Tissue Antigens 1977; 9: 1-7.

  80. Kew MC, Gear AJ, Baumgarten I, Dusheiko GM, Maier G. Histocompatibility antigens in patients with hepatocellular carcinoma and their relationship to chronic hepatitis B virus infection in these patients. Gastroenterology 1979; 77: 537-9.

  81. Maharaj B, Khedun SM, Hammond MG. HLA-antigens in Black patients with hepatocellular carcinoma. East Afr J Med 1997; 74: 705-7.

  82. Williams AO, Edgington GM, Obakponovwe PC. Hepatocellular carcinoma in infancy and childhood in Ibadan, Western Nigeria. Br J Cancer 1967; 21: 474-82.

  83. Cameron HM, Warwick GP. Primary cancer of the liver in Kenyan children. Br J Cancer 1877; 36: 793-803. 84. Kew MC, Hodkinson J, Paterson AC, Song E. Hepatitis B virus infection in Black children with hepatocellular carcinoma. J Med Virol 1982a; 9: 201-7.

  84. Akinyinka OO, Falade AG, Ogunbiyi O, Johnson AO. Hepatocellular carcinoma in Nigerian children. Ann Trop Paediatr 2001; 21: 169-74.

  85. Moore SW, Davidson A, Hadley GP, Kruger M, Poole J, Stones D, et al. Malignant liver tumors in children: A national audit. World J Surg 2008; 32: 1389-95.




2020     |     www.medigraphic.com